Table 2.

Total number of intraductal and tubular carcinomas following treatment with MPA and progesterone implanted at 6 weeks after DMBA treatment

Treatment groupsTotal tumors examinedIntraductal hyperplasia, n (%)Well and poorly differentiated tubular and papillary adenocarcinoma, n (%)
No treatment
DMBA control92 (22.2)7 (77.8)
DMBA + MPA158 (53.3)7 (46.7)
DMBA + progesterone91 (11.1)8 (88.9)